Cargando…

Utilidad de los enjuagues con povidona yodada y peróxido de hidrógeno en pacientes con COVID-19

INTRODUCTION: Povidone-iodine and hydrogen peroxide could be effective in against SARS-CoV-2. METHODS: A “non-interventional trial” in 88 patients (43 ± 17 yrs, 55% men) with SARS-CoV-2 in nasopharyngeal swabs (RT-PCR). 31 received mouth rinses/gargling with povidone-iodine (every 8 h, two consecuti...

Descripción completa

Detalles Bibliográficos
Autores principales: Pablo-Marcos, Daniel, Abascal, Beatriz, Lloret, Lara, Gutiérrez Cuadra, Manuel, Velasco, Nieves, Valero, Carmen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica. Published by Elsevier España, S.L.U. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8542440/
https://www.ncbi.nlm.nih.gov/pubmed/34720312
http://dx.doi.org/10.1016/j.eimc.2021.10.005
_version_ 1784589430406774784
author Pablo-Marcos, Daniel
Abascal, Beatriz
Lloret, Lara
Gutiérrez Cuadra, Manuel
Velasco, Nieves
Valero, Carmen
author_facet Pablo-Marcos, Daniel
Abascal, Beatriz
Lloret, Lara
Gutiérrez Cuadra, Manuel
Velasco, Nieves
Valero, Carmen
author_sort Pablo-Marcos, Daniel
collection PubMed
description INTRODUCTION: Povidone-iodine and hydrogen peroxide could be effective in against SARS-CoV-2. METHODS: A “non-interventional trial” in 88 patients (43 ± 17 yrs, 55% men) with SARS-CoV-2 in nasopharyngeal swabs (RT-PCR). 31 received mouth rinses/gargling with povidone-iodine (every 8 h, two consecutive days), 17 with mouth rinses/gargling of hydrogen peroxide, and 40 controls. PCR were repeated at 3, 11 and 17 days. RESULTS: After intervention the viral load (Log 10 copies/ml) remained similar in povidone-iodine (4.3 ± 2.7 copies/ml), hydrogen peroxide (4.6 ± 2.9 copies/ml; p = 0.40) and controls (4.4 ± 3.0 copies/ml). The percentage of patients with a negative result in the second PCR was 27% in povidone-iodine group, 23% in hydrogen peroxide and 32% in controls; in the third PCR, 62%, 54% and 58% respectively; and in the fourth PCR, 81%, 75% and 81%. CONCLUSION: Our results do not support the clinical usefulness of mouth rinses/gargling with povidone-iodine or hydrogen peroxide in patients with COVID-19.
format Online
Article
Text
id pubmed-8542440
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica. Published by Elsevier España, S.L.U.
record_format MEDLINE/PubMed
spelling pubmed-85424402021-10-25 Utilidad de los enjuagues con povidona yodada y peróxido de hidrógeno en pacientes con COVID-19 Pablo-Marcos, Daniel Abascal, Beatriz Lloret, Lara Gutiérrez Cuadra, Manuel Velasco, Nieves Valero, Carmen Enferm Infecc Microbiol Clin Original Breve INTRODUCTION: Povidone-iodine and hydrogen peroxide could be effective in against SARS-CoV-2. METHODS: A “non-interventional trial” in 88 patients (43 ± 17 yrs, 55% men) with SARS-CoV-2 in nasopharyngeal swabs (RT-PCR). 31 received mouth rinses/gargling with povidone-iodine (every 8 h, two consecutive days), 17 with mouth rinses/gargling of hydrogen peroxide, and 40 controls. PCR were repeated at 3, 11 and 17 days. RESULTS: After intervention the viral load (Log 10 copies/ml) remained similar in povidone-iodine (4.3 ± 2.7 copies/ml), hydrogen peroxide (4.6 ± 2.9 copies/ml; p = 0.40) and controls (4.4 ± 3.0 copies/ml). The percentage of patients with a negative result in the second PCR was 27% in povidone-iodine group, 23% in hydrogen peroxide and 32% in controls; in the third PCR, 62%, 54% and 58% respectively; and in the fourth PCR, 81%, 75% and 81%. CONCLUSION: Our results do not support the clinical usefulness of mouth rinses/gargling with povidone-iodine or hydrogen peroxide in patients with COVID-19. Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica. Published by Elsevier España, S.L.U. 2023-03 2021-10-25 /pmc/articles/PMC8542440/ /pubmed/34720312 http://dx.doi.org/10.1016/j.eimc.2021.10.005 Text en © 2021 Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica. Published by Elsevier España, S.L.U. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Original Breve
Pablo-Marcos, Daniel
Abascal, Beatriz
Lloret, Lara
Gutiérrez Cuadra, Manuel
Velasco, Nieves
Valero, Carmen
Utilidad de los enjuagues con povidona yodada y peróxido de hidrógeno en pacientes con COVID-19
title Utilidad de los enjuagues con povidona yodada y peróxido de hidrógeno en pacientes con COVID-19
title_full Utilidad de los enjuagues con povidona yodada y peróxido de hidrógeno en pacientes con COVID-19
title_fullStr Utilidad de los enjuagues con povidona yodada y peróxido de hidrógeno en pacientes con COVID-19
title_full_unstemmed Utilidad de los enjuagues con povidona yodada y peróxido de hidrógeno en pacientes con COVID-19
title_short Utilidad de los enjuagues con povidona yodada y peróxido de hidrógeno en pacientes con COVID-19
title_sort utilidad de los enjuagues con povidona yodada y peróxido de hidrógeno en pacientes con covid-19
topic Original Breve
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8542440/
https://www.ncbi.nlm.nih.gov/pubmed/34720312
http://dx.doi.org/10.1016/j.eimc.2021.10.005
work_keys_str_mv AT pablomarcosdaniel utilidaddelosenjuaguesconpovidonayodadayperoxidodehidrogenoenpacientesconcovid19
AT abascalbeatriz utilidaddelosenjuaguesconpovidonayodadayperoxidodehidrogenoenpacientesconcovid19
AT lloretlara utilidaddelosenjuaguesconpovidonayodadayperoxidodehidrogenoenpacientesconcovid19
AT gutierrezcuadramanuel utilidaddelosenjuaguesconpovidonayodadayperoxidodehidrogenoenpacientesconcovid19
AT velasconieves utilidaddelosenjuaguesconpovidonayodadayperoxidodehidrogenoenpacientesconcovid19
AT valerocarmen utilidaddelosenjuaguesconpovidonayodadayperoxidodehidrogenoenpacientesconcovid19